Heart Problems Prevalent Among COVID, Smallpox, Anthrax Vaccines: Study

A recent study found that numerous vaccines are associated with myocarditis and pericarditis.

Researchers drew upon data from the World Health Organization (WHO), analyzing records of “vaccine-associated pericarditis and myocarditis between 1969 and 2023.”

There were more than 130 million reports extracted from WHO data.

Using information from 156 countries and 19 different vaccines, the researchers assessed more than 49,000 reports of vaccine-associated heart issues among 73,590 reports of pericarditis and myocarditis.

The researchers noted that there was a “noteworthy surge” in heart problems after 2020, likely associated with the COVID-19 mRNA vaccines.

Despite mRNA being linked to health concerns, the study found that “smallpox vaccines were associated with most pericarditis and myocarditis reports.”

Other vaccines associated with heart problems included the COVID-19 mRNA vaccines, anthrax vaccine, typhoid vaccine, encephalitis vaccine, influenza vaccine, and the Ad5-vectored COVID-19 vaccine.

“Concerning age and sex-specific risks, reports of vaccine-associated pericarditis and myocarditis were more prevalent among males and in older age groups,” the researchers wrote.

Younger males, however, had a shorter time of onset in pericarditis and myocarditis. The research explained that for such demographics, the median time of onset was 1 day, with a 0.44% fatality rate.

Another study found that deaths from a variety of causes have increased following the introduction of the COVID-19 vaccine.

According to the study, conducted by researchers at the University of Turin in Italy, those who received one or two COVID-19 vaccines had “significantly higher risks” than those who were unvaccinated.

“We found all-cause death risks to be even higher for those vaccinated with one and two doses compared to the unvaccinated and that the booster doses were ineffective. We also found a slight but statistically significant loss of life expectancy for those vaccinated with 2 or 3/4 doses,” researchers concluded.